Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease
about
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.Is there a difference in testosterone levels and its regulators in men carrying BRCA mutations?
P2860
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Effect of finasteride on serum ...... on high- and low-grade disease
@ast
Effect of finasteride on serum ...... on high- and low-grade disease
@en
type
label
Effect of finasteride on serum ...... on high- and low-grade disease
@ast
Effect of finasteride on serum ...... on high- and low-grade disease
@en
prefLabel
Effect of finasteride on serum ...... on high- and low-grade disease
@ast
Effect of finasteride on serum ...... on high- and low-grade disease
@en
P2093
P2860
P1433
P1476
Effect of finasteride on serum ...... on high- and low-grade disease
@en
P2093
Adrie vanBokhoven
Alan R Kristal
Ann W Hsing
Ashraful Hoque
Cathee Till
Catherine M Tangen
Douglas K Price
Elizabeth A Platz
Frank Z Stanczyk
Howard L Parnes
P2860
P304
P356
10.1016/J.UROLOGY.2014.11.024
P407
P577
2015-03-01T00:00:00Z